| Gene symbol | VEGFA | Synonyms | L-VEGF, MVCD1, VEGF, VPF | Type of gene | protein-coding | |
| Chromosome | 6 | Map location | 6p21.1 | dbXrefs | Entrez:7422 MIM:192240 HGNC:HGNC:12680 Ensembl:ENSG00000112715 AllianceGenome:HGNC:12680 | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | |||||
| Description | vascular endothelial growth factor A | |||||
| GTO ID | GTC0023 |
| Trial ID | NCT00239928 |
| Disease | Macular Degeneration |
| Altered gene | VEGFA |
| Therapeutic/Target gene | Target gene |
| Therapy | Aptamer |
| Treatment | Macugen|pegaptanib|EYE001 |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Long-Term Study For Pegaptanib Sodium In Patients With Subfoveal Choroidal Neovascularization Secondary To Age-Related Macular Degeneration (Extension Study From A5751010) |
| Year | 2005 |
| Country | Japan |
| Company sponsor | Pfizer |
| Other ID(s) | A5751015 |
| Cohort 1 | |||||||||||
|
|||||||||||